Search Results

Filter
  • 1-10 of  51,062 results for ""Apolipoprotein A-I""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

HDL-C and apolipoprotein A-I are independently associated with skeletal muscle mitochondrial function in healthy humans.

  • Authors : Giacona JM; Hypertension Section, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, United States.; Department of Applied Clinical Research, School of Health Professions, University of Texas Southwestern Medical Center, Dallas, Texas, United States.

Subjects: Lipoproteins, HDL* ; Apolipoprotein A-I*; Adult

  • Source: American journal of physiology. Heart and circulatory physiology [Am J Physiol Heart Circ Physiol] 2024 Apr 01; Vol. 326 (4), pp. H916-H922. Date of Electronic Publication: 2024 Publisher: American Physiological Society Country of Publication: United States NLM ID: 100901228 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Increased Apolipoprotein B/Apolipoprotein A-I Ratio Is Associated With Decline in Lung Function in Healthy Individuals: The Kangbuk Samsung Health Study.

  • Authors : Lee J; Department of Internal Medicine, Jeju National University Hospital, Jeju National University School of Medicine, Jeju, Korea.; Park HK

Subjects: Apolipoprotein A-I* ; Lung Diseases*/Lung Diseases*/Lung Diseases*/blood ; Lung Diseases*/Lung Diseases*/Lung Diseases*/diagnosis

  • Source: Journal of Korean medical science [J Korean Med Sci] 2024 Feb 19; Vol. 39 (6), pp. e51. Date of Electronic Publication: 2024 Feb 19.Publisher: Korean Academy of Medical Science Country of Publication: Korea (South) NLM ID: 8703518 Publication Model: Electronic Cited Medium: Internet

Record details

×
Academic Journal

Lipid exchange of apolipoprotein A-I amyloidogenic variants in reconstituted high-density lipoprotein with artificial membranes.

  • Authors : Correa Y; Biofilm - Research Center for Biointerfaces and Department of Biomedical Science, Faculty of Health and Society, Malmö University, Malmö, Sweden.; Ravel M

Subjects: Lipoproteins, HDL*/Lipoproteins, HDL*/Lipoproteins, HDL*/chemistry ; Lipoproteins, HDL*/Lipoproteins, HDL*/Lipoproteins, HDL*/metabolism ; Apolipoprotein A-I*/Apolipoprotein A-I*/Apolipoprotein A-I*/genetics

  • Source: Protein science : a publication of the Protein Society [Protein Sci] 2024 May; Vol. 33 (5), pp. e4987.Publisher: Cold Spring Harbor Laboratory Press Country of Publication: United States NLM ID: 9211750 Publication Model: Print Cited Medium: Internet

Record details

×
Academic Journal

RVX-208, an inducer of Apolipoprotein A-I, inhibits the particle production of hepatitis B virus through activation of cGAS-STING pathway.

  • Authors : Shu D; School of Bioscience and Technology, Chengdu Medical College, Chengdu, China.; Cheng L

Subjects: Hepatitis B virus* ; Apolipoprotein A-I*/Apolipoprotein A-I*/Apolipoprotein A-I*/genetics ; Apolipoprotein A-I*/Apolipoprotein A-I*/Apolipoprotein A-I*/metabolism

  • Source: Antiviral therapy [Antivir Ther] 2023 Dec; Vol. 28 (6), pp. 13596535231219639.Publisher: SAGE Publications Country of Publication: England NLM ID: 9815705 Publication Model: Print Cited Medium: Internet ISSN: 2040-2058

Record details

×
Academic Journal

Retardation of Aβ42 fibril formation by apolipoprotein A-I and recombinant HDL particles.

  • Authors : Frankel R; Biochemistry and Structural Biology, Lund University, Lund, Sweden; Division of Physical Chemistry, Lund University, Lund, Sweden.

Subjects: Amyloid beta-Peptides* ; Apolipoprotein A-I*; Kinetics

  • Source: The Journal of biological chemistry [J Biol Chem] 2023 Nov; Vol. 299 (11), pp. 105273. Date of Electronic Publication: 2023 Sep 20.Publisher: Elsevier Inc. on behalf of American Society for Biochemistry and Molecular Biology Country of Publication: United States NLM ID: 2985121R Publication

Record details

×
Academic Journal

Predictive and prognostic role of early apolipoprotein A-I alteration in recurrent or metastatic nasopharyngeal carcinoma patients treated with anti-PD-1 therapy.

  • Authors : Xiao BJ; State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, China.; Sima XX

Subjects: Apolipoprotein A-I* ; Nasopharyngeal Carcinoma*/Nasopharyngeal Carcinoma*/Nasopharyngeal Carcinoma*/drug therapy ; Nasopharyngeal Carcinoma*/Nasopharyngeal Carcinoma*/Nasopharyngeal Carcinoma*/secondary

  • Source: Cancer medicine [Cancer Med] 2023 Aug; Vol. 12 (16), pp. 16918-16928. Date of Electronic Publication: 2023 Jul 06.Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Amyloidogenic 60-71 deletion/ValThr insertion mutation of apolipoprotein A-I generates a new aggregation-prone segment that promotes nucleation through entropic effects.

  • Authors : Namba N; Laboratory of Biophysical Chemistry, Kyoto Pharmaceutical University, 5 Misasagi-Nakauchi-cho, Yamashina-ku, Kyoto, 607-8414, Japan.; Ohgita T

Subjects: Apolipoprotein A-I*/Apolipoprotein A-I*/Apolipoprotein A-I*/metabolism ; Amyloid*/Amyloid*/Amyloid*/metabolism; Kinetics

  • Source: Scientific reports [Sci Rep] 2023 Oct 28; Vol. 13 (1), pp. 18514. Date of Electronic Publication: 2023 Oct 28.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Lipoprotein lipids and apolipoproteins in primary immune thrombocytopenia: Results from a clinical characteristics and causal relationship verification, potential drug target identification by Mendelian randomization analyses.

  • Authors : Ou Y; Center for Tumor Diagnosis and Therapy, Jinshan Hospital, Fudan University, Shanghai, China.; Zhan Y

Subjects: Apolipoprotein A-I*/Apolipoprotein A-I*/Apolipoprotein A-I*/genetics ; Purpura, Thrombocytopenic, Idiopathic*/Purpura, Thrombocytopenic, Idiopathic*/Purpura, Thrombocytopenic, Idiopathic*/drug therapy ; Purpura, Thrombocytopenic, Idiopathic*/Purpura, Thrombocytopenic, Idiopathic*/Purpura, Thrombocytopenic, Idiopathic*/genetics

  • Source: British journal of haematology [Br J Haematol] 2024 Apr; Vol. 204 (4), pp. 1483-1494. Date of Electronic Publication: 2023 Nov 30.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Changes in serum amyloid A, plasma high-density lipoprotein cholesterol and apolipoprotein A-I as useful biomarkers for Mycobacterium tuberculosis infection.

  • Authors : Franco Fontes C; The Graduate Program in Medicine and Health, School of Medicine of Bahia, Federal University of Bahia, Salvador, Bahia, Brazil.; Clinical Biochemistry Laboratory, Department of Clinical and Toxicological Analysis, Faculty of Pharmacy, Federal University of Bahia, Salvador, Bahia, Brazil.

Subjects: Apolipoprotein A-I* ; Tuberculosis*/Tuberculosis*/Tuberculosis*/diagnosis; Humans

  • Source: Journal of medical microbiology [J Med Microbiol] 2023 Jun; Vol. 72 (6).Publisher: Microbiology Society Country of Publication: England NLM ID: 0224131 Publication Model: Print Cited Medium: Internet ISSN: 1473-5644

Record details

×
Academic Journal

N-terminal eGFP-tagging of rabbit apolipoprotein A-I decreases expression and impairs cholesterol-efflux activity.

  • Authors : Wacker BK; Department of Medicine, University of Washington School of Medicine, 1959 NE Pacific St, 357710, Seattle, WA 98195, United States of America.; Bi L

Subjects: Apolipoprotein A-I*/Apolipoprotein A-I*/Apolipoprotein A-I*/metabolism ; Cholesterol*/Cholesterol*/Cholesterol*/metabolism; Animals

  • Source: Biochimica et biophysica acta. Molecular and cell biology of lipids [Biochim Biophys Acta Mol Cell Biol Lipids] 2023 May; Vol. 1868 (5), pp. 159301. Date of Electronic Publication: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101731727 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  51,062 results for ""Apolipoprotein A-I""